ZAK-30
110 items |
— ZA 43722 — 2025-12-23 — FDA
New research aims to make FDA-approved drugs safer for the brain
— ZA 43956 — 2025-10-14 — FDA
HIV Self-Testing Just Got Faster: FDA Approves the 1-Minute INSTI® HIV Self Test
— ZA 43615 — 2025-08-05 — FDA
FDA Approves Biktarvy for Patients With HIV Previously Treated With Antiretroviral Therapy
— ZA 43624 — 2025-07-28 — FDA
FDA Approves First HIV Drug That Offers 100-Percent Protection
— ZA 43666 — 2025-07-10 — FDA
FDA Accepts New Drug Application for Merck's HIV Treatment, Doravirine/Islatravir
— ZA 43187 — 2025-06-20 — FDA
FDA approves new twice-yearly HIV prevention shot. Here's how it works
— ZA 43183 — 2025-06-20 — FDA
FDA approves first twice-yearly injection that prevents HIV infection
— ZA 43181 — 2025-06-20 — FDA
Injectable HIV Prevention Drug Gets FDA Nod
— ZA 43210 — 2025-06-11 — FDA
FDA slaps clinical hold on multiple Gilead HIV trials
— ZA 43211 — 2025-06-11 — FDA
US FDA places clinical hold on Gilead trials testing HIV pill combination
— ZA 42717 — 2024-11-14 — FDA
FDA gives Lupin tentative nod for generic Isentress
— ZA 42011 — 2024-05-01 — FDA
Gilead expands FDA label for Biktarvy with Phase I pregnant HIV patient data
— ZA 41512 — 2024-02-28 — FDA
Gilead's Biktarvy receives FDA expanded approval for HIV
— ZA 41507 — 2024-02-28 — FDA
FDA Approves Expanded Indication for HIV Therapy
— ZA 41747 — 2024-01-04 — FDA
FDA is changing the rules for blood donation
— ZA 40953 — 2023-12-15 — FDA
U.S. FDA Approves MedMira's Advanced Reveal G4 Rapid HIV-1/2 Antibody Test
— ZA 41244 — 2023-10-26 — FDA
Stanford Blood Donation Center implements updated FDA guidelines for donor eligibility
— ZA 40532 — 2023-09-07 — FDA
FDA Provides Tentative Approval for HIV Therapy for Children
— ZA 40530 — 2023-09-07 — FDA
FDA tentatively approves generic version of pediatric HIV drug under PEPFAR program
— ZA 40693 — 2023-08-08 — FDA
More gay and bisexual men can donate blood under new FDA guidelines
— ZA 40727 — 2023-08-01 — FDA
Janssen seeks US FDA expanded indication approval for Edurant to include treatment ...
— ZA 40189 — 2023-05-19 — FDA
FDA relaxes blood donation eligibility for gay, bisexual men. Experts say they're 'delighted'
— ZA 40173 — 2023-05-17 — FDA
Who can donate blood? What to know about FDA's new guidelines
— ZA 40175 — 2023-05-17 — FDA
Updated FDA guidelines allow more gay, bisexual men to donate blood
— ZA 40100 — 2023-05-04 — FDA
Laurus gets tentative USFDA nod for paediatric HIV drug
— ZA 39779 — 2023-03-08 — FDA
FDA Approves IM Administration of Merck's MMRV Family of Vaccines
— ZA 39775 — 2023-03-07 — FDA
FDA ban against gay and bisexual men giving blood perpetuates stigma
— ZA 39608 — 2023-02-07 — FDA
FDA amending its rules for gay and bisexual blood donors
— ZA 39591 — 2023-02-01 — FDA
FDA proposes individual risk assessments for blood donors, opening up opportunities for ...
— ZA 39588 — 2023-02-01 — FDA
FDA drafts new 'gender-inclusive' guidance on blood donation eligibility, HIV risk reduction
— ZA 39580 — 2023-01-31 — FDA
What proposed FDA blood donation rules could mean for Arizona's gay, bisexual men
— ZA 39577 — 2023-01-31 — FDA
FDA moves to ease rules for blood donations from gay men
— ZA 39518 — 2023-01-18 — FDA
DiaCarta's MPOX test kit gets emergency use authorization from US FDA
— ZA 39508 — 2023-01-17 — FDA
Lupin gets USFDA tentative nod for generic drugs to treat HIV infection
— ZA 38120 — 2022-10-05 — FDA
USFDA approves Lupin's generic version of HIV/AIDS tablets
— ZA 38208 — 2022-09-22 — FDA
Merck HIV drug trials paused by FDA will resume under modified plan
— ZA 38347 — 2022-08-30 — FDA
Congress must renew crucial FDA funds that support patients across the world
— ZA 38358 — 2022-08-26 — FDA
GlaxoSmithKline's HIV drug Cabenuva scores FDA nod for 2-month dosing
— ZA 38862 — 2022-05-18 — FDA
FDA Lifts Clinical Hold on Lenacapavir for HIV Treatment and PrEP
— ZA 38952 — 2022-04-27 — FDA
FDA approves label update to ViiV's long-acting HIV treatment
— ZA 39076 — 2022-03-31 — FDA
FDA approves long-acting injectable HIV regimen for adolescents
— ZA 39192 — 2022-03-04 — FDA
FDA rejects Gilead's HIV drug lenacapavir over glass vial concerns
— ZA 39201 — 2022-03-03 — FDA
FDA rejects Gilead's closely watched HIV drug
— ZA 39198 — 2022-03-03 — FDA
FDA Rejects Gilead's Long-Acting HIV Drug Over Vial Issues
— ZA 39204 — 2022-03-03 — FDA
U.S. FDA declines to approve Gilead's HIV drug on glass vial concerns
— ZA 39319 — 2022-02-03 — FDA
ViiV Healthcare Announces US FDA Approval of Cabenuva (cabotegravir, rilpivirine) for Use ...
— ZA 39384 — 2022-01-19 — FDA
Could the FDA Lift Its Blood Restriction on Gay and Bi Men?
— ZA 39418 — 2022-01-11 — FDA
With our blood supply at critical levels, the FDA should end its homophobic donation policy
— ZA 39429 — 2022-01-07 — FDA
Hope as FDA approves injectable for HIV prevention
— ZA 39438 — 2022-01-06 — FDA
5 FDA approval decisions to watch in the first quarter
— ZA 39451 — 2022-01-04 — FDA
Our blood supply is at critical levels. The FDA should end its homophobic ...
— ZA 34248 — 2021-12-30 — FDA
FDA approves new injectable PrEP option for HIV prevention, health experts say adherence is key
— ZA 34276 — 2021-12-24 — FDA
US FDA approves cabotegravir extended-release for long-acting HIV PrEP
— ZA 34281 — 2021-12-23 — FDA
A New, Long-Acting HIV Prevention Drug Just Got FDA Approval
— ZA 34284 — 2021-12-23 — FDA
FDA approves first injectable PrEP medication to lower HIV risk
— ZA 34187 — 2021-12-22 — FDA
FDA Approves Cabotegravir LA for Long-Acting HIV Prep
— ZA 34190 — 2021-12-22 — FDA
FDA Approves First Injectable HIV Prevention Drug
— ZA 34192 — 2021-12-21 — FDA
FDA Approves Apretude, Long-acting Injectable Option For HIV Prevention ...
— ZA 34479 — 2021-10-29 — FDA
CytoDyn Announces FDA Accepts Revised Rolling Review
— ZA 34643 — 2021-09-24 — FDA
FDA-approved HIV medication could help patients with movement disorder
— ZA 34756 — 2021-09-02 — FDA
FDA vaccine scientists depart amid booster drama
— ZA 34849 — 2021-08-13 — FDA
FDA to authorize COVID-19 booster shot for immunocompromised
— ZA 35897 — 2020-12-30 — FDA
FDA considers lifting restrictions on blood donations by gay and bi men
— ZA 36203 — 2020-10-23 — FDA
NY lawmaker launches 'Give for a Gay' blood drive to highlight FDA's discriminatory policy banning ...
— ZA 36329 — 2020-09-25 — FDA
First-Time Blood Donors: Has the Incidence of HIV Changed With New FDA Rules?
— ZA 36706 — 2020-07-08 — FDA
GSK snags first-in-class FDA nod for Rukobia to treat HIV patients who have few options
— ZA 36733 — 2020-07-02 — FDA
The FDA's gay and bi blood-donor ban isn't just stigmatizing—it's also likely outdated
— ZA 37144 — 2020-04-07 — FDA
The new FDA regulations are still bloodless discriminatory rhetoric
— ZA 37150 — 2020-04-03 — FDA
GLAAD criticizes FDA ban on blood and plasma donations from gay and bisexual men during ...
— ZA 37167 — 2020-04-01 — FDA
Hey FDA! There's a Massive Blood Shortage. Let Gay and Bisexual Men Give Blood Already.
— ZA 37215 — 2020-03-20 — FDA
Blood shortage should encourage FDA to lift ban on who can donate
— ZA 34157 — 2019-12-24 — FDA
FDA rejects ViiV's long-acting monthly HIV injection
— ZA 33921 — 2019-11-08 — FDA
FDA Authorizes New Type of Test to Find Drug-Resistant HIV
— ZA 33849 — 2019-10-24 — FDA
Packaging Solution Approved by US FDA for Oral Solid Dose HIV Prevention Medicine
— ZA 33758 — 2019-10-07 — FDA
FDA Approves New PrEP Medication
— ZA 33471 — 2019-08-15 — FDA
FDA warns public that drinking bleach won't cure autism, cancer, HIV
— ZA 33472 — 2019-08-15 — FDA
FDA approves new drug for Pulmonary Multidrug-Resistant TB in children
— ZA 33462 — 2019-08-14 — FDA
FDA Committee Recommends Approval of Descovy for HIV PrEP Indication
— ZA 32825 — 2019-04-17 — FDA
FDA Has Approved New Two-Drug Regimen to Treat People with HIV
— ZA 32120 — 2018-12-06 — FDA
HIV self-test app connects users to care, FDA proposes De Novo update, and more digital health ...
— ZA 32004 — 2018-11-15 — FDA
FDA's blood donation ban for gay, bisexual men is homophobic
— ZA 31628 — 2018-09-05 — FDA
Top stories in infectious disease: FDA approves treatments for HIV, CDC reports record number of ...
— ZA 31614 — 2018-09-04 — FDA
FDA Approves Two New Drugs for HIV
— ZA 31160 — 2018-05-23 — FDA
FDA Draft Guidance on Pediatric HIV Infection: Drug Development for Treatment
— ZA 31123 — 2018-05-17 — FDA
FDA approves Truvada for PrEP in teenagers
— ZA 30726 — 2018-03-14 — FDA
Strides Shasun gets USFDA nod for HIV treatment drug
— ZA 30681 — 2018-03-07 — FDA
FDA Approves Therapy for Previously Treated HIV Patients
— ZA 29363 — 2017-08-02 — FDA
US FDA approves updated labeling for pan-genotypic single tablet regimen for HCV/HIV co
— ZA 27982 — 2016-12-21 — FDA
How the FDA promotes homophobia in the medical world
— ZA 27293 — 2016-09-01 — FDA
FDA considers changing gay blood ban
— ZA 26859 — 2016-06-20 — FDA
FDA rules still block many gay, bisexual men from giving blood
— ZA 26087 — 2016-02-17 — FDA
FDA moves to protect blood donations from Zika virus
— ZA 25809 — 2016-01-07 — FDA
FDA drops lifetime ban on blood donations from gay and bisexual men
— ZA 25759 — 2015-12-31 — FDA
FDA Announced That Bisexual Men Permitted To Donate Blood
— ZA 23869 — 2015-06-04 — FDA
Cipla gets US FDA approval for Lopinavir, Ritonavir oral pellets to treat AIDS in infants
— ZA 22696 — 2015-02-02 — FDA
New HIV Drug Approved By FDA
— ZA 22356 — 2014-12-26 — FDA
31 year old ban on blood donations from gay men eased by FDA
— ZA 22276 — 2014-12-17 — FDA
Elizabeth Warren Just Took a Major Stand Against the FDA's Homophobia
— ZA 20906 — 2014-07-29 — FDA
The FDA Is Perpetuating Homophobia — Here's the Ridiculously Simple Reason It Has to Stop
— ZA 18297 — 2014-01-07 — FDA
New FDA-Approved Treatments May Make Lives Easier for Hepatitis ...
— ZA 16044 — 2013-08-14 — FDA
Rapid HIV Test Approved by US FDA
— ZA 16009 — 2013-08-13 — FDA
US FDA approves GSK's HIV-1 drug
— ZA 15998 — 2013-08-12 — FDA
FDA Approves First 4th-generation Rapid HIV Diagnostic Test
— ZA 14270 — 2013-05-01 — FDA
FDA rejects 2 HIV drugs from Gilead Sciences - The Times and Democrat
— ZA 14248 — 2013-04-30 — FDA
FDA rejects two Gilead HIV drugs as standalone products
— ZA 14240 — 2013-04-30 — FDA
FDA rejects two HIV drugs as stand-alone treatments
— ZA 14239 — 2013-04-30 — FDA
FDA rejects 2 HIV drugs from Gilead Sciences
— ZA 12255 — 2013-01-04 — FDA
FDA approves first anti-diarrheal drug for HIV/AIDS patient, Salix Pharma's ...
— ZA 12215 — 2013-01-02 — FDA
FDA clears Salix anti-diarrheal for HIV patients
— ZA 7700 — 2012-04-10 — FDA
FDA ban on blood donations from gay men reduces number of possible contributors